The revenue stands at ₹4,921.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.25 per cent from ₹4,197.00 crore. This corresponds to a year-on-year *(YoY) growth of 54.85 per cent.
Operating Profit stands at ₹1,643.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.36 per cent from ₹1,290.00 crore. This corresponds to a year-on-year *(YoY) growth of 59.21 per cent.
PBDT stands at ₹1,326.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 27.87 per cent from ₹1,037.00 crore. This corresponds to a year-on-year *(YoY) growth of 41.21 per cent.
Profit Before Tax stands at ₹733.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 38.56 per cent from ₹529.00 crore. This corresponds to a year-on-year *(YoY) decline of 0.68 per cent.
Net Profit stands at ₹566.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 55.49 per cent from ₹364.00 crore. This represents a 3.28 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Torrent Pharma. | 0.48% | -0.49% | -2.75% | -1.57% | 18.00% | 34.85% |
| Sun Pharma.Inds. | 1.07% | -1.04% | -5.20% | -5.36% | 4.80% | 8.87% |
| Divi's Lab. | 3.61% | 2.83% | 2.58% | 40.98% | 63.18% | 56.43% |
| Zydus Lifesci. | 1.89% | -0.29% | 0.43% | 0.62% | 32.78% | 17.44% |
| Laurus Labs | 4.58% | 3.65% | 9.94% | 39.08% | 94.43% | 137.99% |
| Cipla | 0.67% | -0.52% | -3.79% | -7.53% | 11.71% | -11.28% |
Chairman/ED & CEO : Samir Mehta
ED / MD / Promoter : Aman Mehta
Non-Exec & Non-Independent Dir : Jindal Mehta
Lead Independent Non Executive Director : Manish Choksi
Independent Non Exe. Director : Nayantara Bali
Independent Non Exe. Director : Nikhil Khattau
Company Sec. & Compli. Officer : Chintan M. Trivedi
Chairman Emeritus : Sudhir Mehta